Presentation is loading. Please wait.

Presentation is loading. Please wait.

Immunoreactivity for the lipocalin 2 (LCN2) receptor (SLC22A17), glial fibrillary acidic protein (GFAP), Iba-1 and neuronal nuclei (NeuN) 24 h after intraventricular.

Published byElla Bradley Modified over 5 years ago

Similar presentations

Presentation on theme: "Immunoreactivity for the lipocalin 2 (LCN2) receptor (SLC22A17), glial fibrillary acidic protein (GFAP), Iba-1 and neuronal nuclei (NeuN) 24 h after intraventricular."— Presentation transcript:

1 Immunoreactivity for the lipocalin 2 (LCN2) receptor (SLC22A17), glial fibrillary acidic protein (GFAP), Iba-1 and neuronal nuclei (NeuN) 24 h after intraventricular haemoglobin injection. Immunoreactivity for the lipocalin 2 (LCN2) receptor (SLC22A17), glial fibrillary acidic protein (GFAP), Iba-1 and neuronal nuclei (NeuN) 24 h after intraventricular haemoglobin injection. Co-localisation of the LCN2 receptor with GFAP, Iba-1 and NeuN by double labelling is shown. Scale bar=50 µm. Hajime Shishido et al. Stroke Vasc Neurol 2016;1:37-43 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to

Download ppt "Immunoreactivity for the lipocalin 2 (LCN2) receptor (SLC22A17), glial fibrillary acidic protein (GFAP), Iba-1 and neuronal nuclei (NeuN) 24 h after intraventricular."

Similar presentations

Graph comparing baseline data with data collected following PDSA cycle 1 (initial introduction of the checklist). PDSA, plan do study act; IV, intravenous.

Graph comparing baseline data with data collected following PDSA cycle 1 (initial introduction of the checklist). PDSA, plan do study act; IV, intravenous.
Percentage of patients attending for GP steroid review following steroid letter. GP, general practitioner; LTOC, long-term oral corticosteroids. Percentage.

Percentage of patients attending for GP steroid review following steroid letter. GP, general practitioner; LTOC, long-term oral corticosteroids. Percentage.
Summary of project team improvement efforts

Summary of project team improvement efforts
Flow diversion concept: placement of a high-mesh density stent (flow diverter) in the parent vessel disrupts blood flow into the aneurysm (A and B), allowing.

Flow diversion concept: placement of a high-mesh density stent (flow diverter) in the parent vessel disrupts blood flow into the aneurysm (A and B), allowing.
WEB treatment of MCA bifurcation aneurysms.

WEB treatment of MCA bifurcation aneurysms.
Flow diversion treatment of a large left cavernous aneurysm with complete occlusion of the aneurysm demonstrated at 6-month follow-up angiogram. Flow diversion.

Flow diversion treatment of a large left cavernous aneurysm with complete occlusion of the aneurysm demonstrated at 6-month follow-up angiogram. Flow diversion.
Effect of interventions on % appointments not attended

Effect of interventions on % appointments not attended
The poster displayed across the wards and on our Trust intranet

The poster displayed across the wards and on our Trust intranet
The guidelines for reversing warfarin and NOAC coagulopathies in patients with symptomatic ICH. ICH, intracerebral haemorrhage. The guidelines for reversing.

The guidelines for reversing warfarin and NOAC coagulopathies in patients with symptomatic ICH. ICH, intracerebral haemorrhage. The guidelines for reversing.
Percentage of newborns admitted to neonatal intensive care unit with axillary temperature over 36.5°C on arrival (July 2016–April 2017). Percentage of.

Percentage of newborns admitted to neonatal intensive care unit with axillary temperature over 36.5°C on arrival (July 2016–April 2017). Percentage of.
Cumulative colorectal cancer mortality and all-cause mortality in persons in Vejle and Copenhagen counties invited to screening and in persons in the rest.

Cumulative colorectal cancer mortality and all-cause mortality in persons in Vejle and Copenhagen counties invited to screening and in persons in the rest.
Figure 2 Brain biopsy Brain biopsy (A) Double staining with anti-aquaporin-4 (AQP4) antibody (dark green) and Luxol fast blue (blue) is shown. Loss of.

Figure 2 Brain biopsy Brain biopsy (A) Double staining with anti-aquaporin-4 (AQP4) antibody (dark green) and Luxol fast blue (blue) is shown. Loss of.
Percentage of newborns admitted to neonatal intensive care unit with axillary temperature below 36°C on arrival (July 2016–April 2017). Percentage of newborns.

Percentage of newborns admitted to neonatal intensive care unit with axillary temperature below 36°C on arrival (July 2016–April 2017). Percentage of newborns.
Long-term appearances of lacunar infarcts (arrows: old stroke lesion on the follow-up scans). Long-term appearances of lacunar infarcts (arrows: old stroke.

Long-term appearances of lacunar infarcts (arrows: old stroke lesion on the follow-up scans). Long-term appearances of lacunar infarcts (arrows: old stroke.
Detection of microemboli by transcranial Doppler identifies high-risk asymptomatic carotid stenosis. Detection of microemboli by transcranial Doppler identifies.

Detection of microemboli by transcranial Doppler identifies high-risk asymptomatic carotid stenosis. Detection of microemboli by transcranial Doppler identifies.
Mortality from CHD and stroke in women and men, by country and year.

Mortality from CHD and stroke in women and men, by country and year.
Microemboli during deployment of a carotid stent.

Microemboli during deployment of a carotid stent.
Effects of statins (hydroxymethylglutarate (HMG) coenzyme A reductase inhibitors) on synthesis of ubiquinone (coenzyme Q10, CoQ10). Effects of statins.

Effects of statins (hydroxymethylglutarate (HMG) coenzyme A reductase inhibitors) on synthesis of ubiquinone (coenzyme Q10, CoQ10). Effects of statins.
Fishbone diagram of the cause-and-effect analysis

Fishbone diagram of the cause-and-effect analysis
The guidelines for reversing warfarin and NOAC coagulopathies in patients with symptomatic ICH. ICH, intracerebral haemorrhage. The guidelines for reversing.

The guidelines for reversing warfarin and NOAC coagulopathies in patients with symptomatic ICH. ICH, intracerebral haemorrhage. The guidelines for reversing.

Similar presentations

Ads by Google